Development of a multiple-unit tablet containing enteric-coated pellets

Pharmaceutical Development and Technology

Volumn 16, Issue 2, 2011, Pages 118-126

  Dreu, Rok ^a   Ilić, Ilija ^a   Srčič, Stanko ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Coating; dissolution; release delay; segregation; tableting

Indexed keywords

EUDRAGIT; MICROCRYSTALLINE CELLULOSE; POVIDONE; TARTRAZINE;

ARTICLE; DELAYED RELEASE FORMULATION; DRUG SOLUBILITY; ENTERIC COATED TABLET; MASS; PRIORITY JOURNAL; TABLET COMPRESSION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS;

CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; SOLUBILITY; TABLETS, ENTERIC-COATED;

EID: 79953061268     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450903499382     Document Type: Article

References (42)

1. Ghebre-Sellassie I. Multiparticulate oral drug delivery. New York: Marcel Dekker; 1994.
2. Bechgaard H, Nielsen GH. Controlled release multiple-units and single-unit doses. A literature review. Drug Dev Ind Pharm 1978;4(1):53-67.
3. Clarke GM, Newton JM, Short MB. Comparative gastrointes-tinal transit of pellet systems of varying density. Int J Pharm 1995;114(1):1-11. (Pubitemid 24377024)
4. Beckert TE, Lehmann K, Schmidt PC Compression of enteric-coated pellets to disintegrating tablets: uniformity of dosage units. Powder Technol 1998;96(3):248-254. (Pubitemid 28179460)
5. Bodmeier R. Tableting of coated pellets. Eur J Pharm Biopharm 1997;43(1):1-8. (Pubitemid 28298804)
6. Bérchard SR, Leroux JC Coated pelletized dosage form: Efect of compaction on drug release. Drug Dev Ind Pharm 1992;18(18):1927-1944.
7. Hermelin VM. Timed release pharmaceutical preparations and method of making the same. U.S. patent 3,115,441, 1963.
8. Hsiao CH. Sustained release quinidine dosage form. U.S. patent 4,634,587, 1987.
9. Hsiao CH, Chou T. Controlled release potassium chloride. U.S. patent 4,863,743, 1989.
10. Hsiao CH.Aspirin tablet. U.S. patent 4,555,399, 1985.
11. Sandberg A, Ragnarsson G, Jonsson UE, Sjögren J. Design of a new multiple-unit controlled-release formulation of metoprolol-Metoprolol CR. Eur J Clin Pharmacol 1988;33(suppl. 1):S3-7. (Pubitemid 18080230)
12. Petersen K-U, Schmutzler W. Proton pump inhibitors. Active sub-stance release from diferent preparations. Deutsche Apotheker Zeitung 1999;139(1):68-69. (Pubitemid 29045552)
13. Lehmann K, Petereit H-U, Dreher D. Fast disintegrating con-trolled release tablets from coated particles. Pharm Ind 1993;55(10):940-947. (Pubitemid 23329213)
14. Beckert TE, Lehmann K, Schmidt PC Compression of enteric-coated pellets to disintegrating tablets. Int J Pharm 1996;143(1):13-23. (Pubitemid 26396395)
15. Wagner KG, Krumme M, Beckert TE, Schmidt PC Development of disintegrating multiple-unit tablets on a high-speed rotary tablet press. Eur J Pharm Biopharm 2000;50(2):285-291.
16. Shimizu T, Nakano Y, Morimoto S, Tabata T, Hamaguchi N, Igari Y Formulation study for lansoprazole fast-disintegrating tablet. I. Efect of compression on dissolution behaviour. Chem Pharm Bull 2003;51(8):942-947. (Pubitemid 41656777)
17. Dashevsky A, Kolter K, Bodmeier R. Compression of pellets coated with various aqueous polymer dispersions. Int J Pharm 2004;279(1-2):19-26. (Pubitemid 38968638)
18. López-Rodríguez FJ, Torrado JJ, Torrado S, Escamilla C, Cadórniga R, Augsburger LL. Compression behaviour of acetylsal-icylic acid pellets. Drug Dev Ind Pharm 1993;19(12):1369-1377. (Pubitemid 23189731)
19. Aulton ME, Dryer AM, Khan KA. Te strength and compaction of millispheres: Te design of a controlled-release drug deliv-ery system for ibuprofen in the form of a tablet comprising compacted polymer-coated millispheres. Drug Dev Ind Pharm 1994;20(20):3069-3104.
20. Torrado JJ, Augsburger LL. Efect of diferent excipients on the tab-leting of coated particles. Int J Pharm 1994;106(2):149-155. (Pubitemid 24136533)
21. Haubitz H, Mehnert W, Frömming K-H. Preparation of theophyl-line multiple units tablets. Pharm Ind 1996;58(1):83-86. (Pubitemid 26060623)
22. Lundqvist ÅEK, Podczeck F, Newton JM. Compaction of, and drug release from, coated drug pellets mixed with other pellets. Eur J Pharm Biopharm 1998;46(3):369-379. (Pubitemid 29057686)
23. Wagner KG, Krumme M, Schmidt PC Investigation of the pel-let-distribution in single tablet via image analysis. Eur J Pharm Biopharm 1999;47(1):79-85. (Pubitemid 29137759)
24. El-Mahdi IM, Deasy PB. Tableting of coated ketoprofen pellets. J Microencapsul 2000;17(2):133-144. (Pubitemid 30135791)
25. Vergote GJ, Kiekens F, Vervaet C, Remon JP. Wax beads as cush-ioning agents during the compression of coated diltiazem pellets. Eur J Pharm Sci 2002;17(3):145-151. (Pubitemid 35248268)
26. Debunne A, Vervaet C, Mangelings D, Remon JP. Compaction of enteric-coated pellets: Infuence of formulation and process parameters on tablet properties and in vivo evaluation. Eur J Pharm Sci 2004;22(4):305-314. (Pubitemid 38758018)
27. Shimizu T, Sugaya M, Nakano Y Izutsu D, Mizukami Y Okochi K, Tabata T, Hamaguchi N, Igari Y Formulation study for lansopra-zole fast-disintegrating tablet. III. Design of rapidly disintegrating tablet. Chem Pharm Bull 2003;51(10):1121-1127. (Pubitemid 41663066)
28. Abbaspour MR, Sadeghi F, Afrasiabi Garekani H Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets. Eur J Pharm Biopharm 2008;68(3):747-759. (Pubitemid 351318223)
29. Łunio R, Sawicki W, Skocze? P, Walentynowicz O, Kubasik-Juraniec J. Compressibility of gastroretentive pellets coated with Eudragit NE using a single-stroke and a rotary tablet press. Pharm Dev Technol 2008;13(4) 323-331.
30. Picker KM. "Soft tableting:" A new concept to tablet pressure-sensitive materials. Pharm Dev Technol 2004;9(1):107-121. (Pubitemid 38250231)
31. European Pharmacopoeia. 6th ed. Council of Europe, Strasbourg, France: Directorate for the Quality of Medicines & HealthCare (EDQM); 07/2009.
32. Mroz C. Monograph: Coloring agents (Table VII and X). In: Rowe RC, Sheskey PJ, Owen SC, editors. Pharmaceutical excipients 5. Pharmaceutical Press and American Pharmacists Association. Electronic version. December 2005.
33. Guidelines for formulation development and process technology for enteric coatings. Evonik Röhm GmbH website. http://www. pharma-polymers.com/ pharmapolymers/en/downloads/. Accessed August, 2009.
34. Bodmeier R, Paeratakul O. Mechanical properties of dry and wet cellulosic and acrylic flms prepared from aqueous colloidal poly-mer dispersions. Pharm Res 1994;11(6):882-888. (Pubitemid 24210626)
35. Acrylic polymers for solid oral dosage forms. Evonik Röhm GmbH website. http://www.pharma-polymers.com/NR/rdonlyres/3D19A053-7628-41B1-BC52- 123763B75566/0/080 620FinalProduktbrosch%C3%BCre.pdf. Accessed August, 2009.
36. Eiliazadeh B, Pitt K, Briscoe B. Efects of punch geometry on powder movement during pharmaceutical tabletting processes. Int J Solids Struct 2004;41(21):5967-5977.
37. Sinka IC, Cunningham JC, Zavaliangos A. Te efect of wall fric-tion in the compaction of pharmaceutical tablets with curved faces: A validation study of the Drucker-Prager Cap model. Powder Tech 2003;133(1-3):33-43. (Pubitemid 36952159)
38. Sinka IC, Burch SF, Tweed JH, Cunningham JC Measurement of density variations in tablets using X-ray computed tomography. Int J Pharm 2004;271(1-2):215-224 (Pubitemid 38210099)
39. FMC BioPolymer website. http://www.fmcbiopolymer.com/pharmaceutical/ Products/Avicelforsoliddoseforms/tabid/2920/Default.aspx. Accessed August, 2009.
40. Larhrib H, Wells JI, Rubinstein MH. Compressing polyethylene glycols: the efect of compression pressure and speed. Int J Pharm 1997;147(2):199-205. (Pubitemid 27132866)
41. Lim CW, Cham T-M. Compression behaviour and tensile strength of heat-treated polyethylene glycols. Int J Pharm 1995;118(2):169-179.
42. AbuBaker OA, Pipkorn D. Monograph: Copovidone.In Rowe RC, Sheskey PJ, Owen SC, editors. Pharmaceutical excipients 5. Pharmaceutical Press and American Pharmacists Association. Electronic version. December 2005.